BD has increased its manufacturing capacity for critical medical supplies, including syringes, needles and IV ... shut down a facility in Ireland over 2 1/2 years, potentially resulting in the ...

It has only been modified to comply with this publication’s space and style. The new solution features Cap-Lock, a functional label from Schreiner MediPharm that, in combination with the SCHOTT ...

The additional production lines at its plant in Sandy, Utah, follows previous investments of more than $12 million in its U.S. manufacturing network to increase its supply of syringes, needles and ...

A Plastipak syringe in use. [Image courtesy of BD] BD (NYSE: BDX) + announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical medical devices.